639
Views
19
CrossRef citations to date
0
Altmetric
Research Article

An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System

, , , &
Pages 969-972 | Received 23 Jun 2014, Accepted 22 Sep 2014, Published online: 13 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Alexander M. Sidlak, Karl O. Koivisto, Ryan T. Marino & Michael G. Abesamis. (2020) Serotonin toxicity from isolated bupropion overdoses. Clinical Toxicology 58:12, pages 1347-1349.
Read now
Steve Offerman, Jasmin Gosen, Stephen H. Thomas, Angie Padilla-Jones, Anne-Michelle Ruha & Michael Levine. (2020) Bupropion associated seizures following acute overdose: who develops late seizures. Clinical Toxicology 58:12, pages 1306-1312.
Read now
Andrew C Naglich, E. Sherwood Brown & Bryon Adinoff. (2019) Systematic review of preclinical, clinical, and post-marketing evidence of bupropion misuse potential. The American Journal of Drug and Alcohol Abuse 45:4, pages 341-354.
Read now
David C. Sheridan, Amber Lin & B. Zane Horowitz. (2018) Suicidal bupropion ingestions in adolescents: increased morbidity compared with other antidepressants. Clinical Toxicology 56:5, pages 360-364.
Read now

Articles from other publishers (14)

Omid Mehrpour, Farhad Saeedi, Varun Vohra, Jafar Abdollahi, Farshad M. Shirazi & Foster Goss. (2023) The role of decision tree and machine learning models for outcome prediction of bupropion exposure: A nationwide analysis of more than 14 000 patients in the United States. Basic & Clinical Pharmacology & Toxicology 133:1, pages 98-110.
Crossref
Kathleen R. McNealy, Lucas Weyrich & Rick A. Bevins. (2023) The co-use of nicotine and prescription psychostimulants: A review of their behavioral and neuropharmacological interactions. Drug and Alcohol Dependence 248, pages 109906.
Crossref
Johanna J. Nugteren-van Lonkhuyzen, Sharon Essink, Saskia J. Rietjens, Dana Ohana, Dylan W. de Lange, Antoinette J.H.P. van Riel & Laura Hondebrink. (2022) 3-Methylmethcathinone (3-MMC) Poisonings: Acute Clinical Toxicity and Time Trend Between 2013 and 2021 in the Netherlands. Annals of Emergency Medicine 80:3, pages 203-212.
Crossref
Daniel J. McCabe, Eric McGillis & Benjamin A. Willenbring. (2022) The Timing of Clinical Effects of Bupropion Misuse Via Insufflation Reported to a Regional Poison Center. The Journal of Emergency Medicine 62:2, pages 175-181.
Crossref
Brittany Debeltz. (2021) Educational Intervention for Bupropion Abuse Prevention. Journal of Doctoral Nursing Practice 14:1, pages 34-42.
Crossref
Yousif Al-Saiegh, Jenna Spears, Pieter S. De Klerk, Joshua Hitchings, Christopher Lee & Tamara Mahr. (2020) A Rare Case of ARDS Caused by Bupropion Inhalation and Treated with Noninvasive Ventilation. Case Reports in Critical Care 2020, pages 1-3.
Crossref
Jamir Pitton Rissardo & AnaLetícia Fornari Caprara. (2020) Bupropion-associated movement disorders: A systematic review. Annals of Movement Disorders 3:2, pages 86.
Crossref
Steve Offerman, Michael Levine, Jasmin Gosen & Stephen H. Thomas. (2019) Pediatric Bupropion Ingestions in Adolescents vs. Younger Children—a Tale of Two Populations. Journal of Medical Toxicology 16:1, pages 6-11.
Crossref
Peter Wu & David Juurlink. 2017. Critical Care Toxicology. Critical Care Toxicology 965 974 .
Gina L Stassinos & Wendy Klein-Schwartz. (2016) Bupropion “Abuse” Reported to US Poison Centers. Journal of Addiction Medicine 10:5, pages 357-362.
Crossref
Peter Wu & David Juurlink. 2016. Critical Care Toxicology. Critical Care Toxicology 1 10 .
Jinyoung Kim, Minseob Kim, Yoo-ra Kim, Kyoung Ho Choi & Kyoung-Uk Lee. (2015) High Prevalence of Psychotropics Overdose among Suicide Attempters in Korea. Clinical Psychopharmacology and Neuroscience 13:3, pages 302-307.
Crossref
. (2015) Bupropion abuse. Reactions Weekly 1571:1, pages 44-44.
Crossref
Jonathan Smithson & Philip B. Mitchell. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 15 31 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.